Ignite Creation Date:
2024-05-05 @ 4:53 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00331799
Status:
COMPLETED
Last Update Posted:
2013-08-02
First Post:
2006-05-30
Brief Title:
Pilot Study of Duloxetine in Psychological Resilience
Sponsor:
Duke University
Organization:
Duke University
Study Overview
Official Title:
A Pilot Study of Duloxetine in Psychological Resilience and Its Correlation With Blockade of Serotonin and Norepinephrine Transporter
Status:
COMPLETED
Status Verified Date:
2013-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to explore benefits of duloxetine in enhancing psychological resilience and to understand the relevance of inhibiting of both serotonin 5HT and norepinephrine NEto therapeutic responses
Detailed Description:
This is an investigator-initiated single-site study consisting of 8 weeks of open-label fixed-dose treatment with duloxetine 30mg-60mgday in patients with Major Depressive Disorder MDD
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None